Pharmaceutical company Chongqing Zhifei Biological Products received permission of the Chinese authorities to start clinical trials of another vaccine against coronavirus.
the Sixth Chinese version of “antidote” is a recombinant vaccine, developed jointly by a subsidiary of the company and the Institute of Microbiology, Chinese Academy of Sciences.
the Search for volunteers was launched on 20 June — the day after the green light was given, the state Administration for supervision of food and drugs.
This is the second recombinant vaccine in the world, which managed to reach the stage of clinical trials. Her older “sister” based on adenoviral vectors have also been developed in China. In addition, China has introduced four inactivated vaccines.
Recall that in China over the past day were detected 29 new cases of coronavirus, seven of which are asymptomatic. All local cases were confirmed in Beijing, where a new outbreak of the disease on the wholesale market, “Sinhali” in Fengtai district.
Stories about how you tried to get help from the Russian state in terms of coronaries and what came of it, email it to COVID-19@rosbalt.ru
